REGENERON PHARMACEUTICALS, INC. (REGN) Free cash flow 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$4.1BFY2025 · since FY2016: $974.0M → $4.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.1B | +11.3% |
| FY2024 | $3.7B | -5.4% |
| FY2023 | $3.9B | -12.4% |
| FY2022 | $4.4B | -32.2% |
| FY2021 | $6.5B | +225.9% |
| FY2020 | $2.0B | +0.2% |
| FY2019 | $2.0B | +10.4% |
| FY2018 | $1.8B | +75.2% |
| FY2017 | $1.0B | +6.2% |
| FY2016 | $974.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice